Can Haematology Blood Tests at Time of Diagnosis Predict Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer?
Conclusion: Routinely collected haematology samples at the point of diagnosis can assist in predicting for complete response to neoadjuvant therapy. Although novel biomarkers will have a greater predictive value, this clinically available value test could help to assist in risk stratification of patients using routinely collected laboratory tests.Dig Surg
Source: Digestive Surgery - Category: Surgery Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Databases & Libraries | Laboratory Medicine | Neoadjuvant Therapy | Rectal Cancers | Study | Surgery